Publications by authors named "Linnea Chap"

Claim this Profile
I
Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials.
Andrea Blasco, Sara López-Tarruella, Ander Urruticoechea, Eva Carrasco, Gonzalo Spera, Linnea Chap

Oncologist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies.
José A García-Saenz, Gonzalo Spera, Marina Pollán, Begoña Bermejo, Manuel Ruiz-Borrego, Linnea Chap

Int J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
R C Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Linnea I Chap

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
R C Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Linnea I Chap

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
R C Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Linnea I Chap

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors.
Komal Jhaveri, Kathy Miller, Lee Rosen, Bryan Schneider, Linnea Chap

Clin Cancer Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review.
Lee S Rosen, Helen Louise Ashurst, Linnea Chap

Oncologist· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
Roy S Herbst, David Hong, Linnea Chap, Razelle Kurzrock, Edward Jackson

J Clin Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant docetaxel for node-positive breast cancer.
Miguel Martin, Tadeusz Pienkowski, John Mackey, Marek Pawlicki, Jean-Paul Guastalla, Linnea Chap

N Engl J Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
Kathy D Miller, Linnea I Chap, Frankie A Holmes, Melody A Cobleigh, P Kelly Marcom

J Clin Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis